Financial Information

Consolidated Balance Sheet

Assets(¥ million)
116th period 117th period
Month of Settlement March 2020 March 2021
Current Assets 33,421 34,197
Fixed Assets 26,331 27,016
Breakdown Tangible fixed Assets 20,808 20,697
Intangible fixed assets 473 954
Investment and other assets 5,049 5,364
Total Assets 59,752 61,214
Liabilities(¥ million)
116th period 117th period
Month of settlement March 2020 March 2021
Current liabilities 14,175 14,622
Fixed Liabilities 8,358 8,514
Total liabilities 22,533 23,136
Net Assets(¥ million)
116th period 117th period
Settlement Date March 2020 March 2021
Stockholders' Equity 36,158 36,824
Breakdown Capital 5,451 5,451
Capital Surplus 4,186 4,186
Retained Earnings 26,534 27,201
Treasury Stock △15 △15
Accumulated Other Comprehensive Income 1,060 1,253
Breakdown Valuation Difference on Other Securities 129 271
Foreign Currency Translation Adjustment Account △28 △70
Accumulated Adjustment for Retirement Benefits 959 1,052
Total Net Assets 37,218 38,078
Total Liabilities and Net Assets 59,752 61,214

Consolidated Statement of Income

(¥ million)
116th period 117th period
Month of settlement March 2020 March 2021
Net sales 44,063 41,528
Cost of sales 29,182 28,158
Gross profit 14,880 13,369
Selling, general and administrative expenses 11,905 11,181
Other income 208 237
Other expenses 88 167
Ordinary income 3,095 2,070
Extraordinary income 190 0
Extraordinary loss 798 169
Income before income taxes 2,487 1,900
Income taxes-deferred 669 422
Net income 1,751 1,350
Net income attributable to non-controlling shareholders - -
Net income attributable to owners of parent 1,751 1,350

Consolidated Cash Flow

(¥ million)
116th period 117th period
Month of settlement March 2020 March 2021
Cash flows from operating activities 5,749 5,614
Cash flows from investing activities △1,380 △2,767
Cash flows from financing activities △916 △775
Exchange differences on cash and cash equivalents △2 △0
Change in cash and cash equivalents 3,450 2,071
Cash and cash equivalents at beginning of year 7,822 11,273
Cash and cash equivalents at end of year 11,273 13,344

Capital Investment and Depreciation

Share this page

IR Support